全文获取类型
收费全文 | 5389篇 |
免费 | 356篇 |
国内免费 | 160篇 |
专业分类
耳鼻咽喉 | 1篇 |
儿科学 | 47篇 |
妇产科学 | 20篇 |
基础医学 | 886篇 |
口腔科学 | 10篇 |
临床医学 | 466篇 |
内科学 | 1622篇 |
皮肤病学 | 14篇 |
神经病学 | 10篇 |
特种医学 | 71篇 |
外国民族医学 | 2篇 |
外科学 | 106篇 |
综合类 | 1088篇 |
预防医学 | 915篇 |
眼科学 | 1篇 |
药学 | 320篇 |
2篇 | |
中国医学 | 113篇 |
肿瘤学 | 211篇 |
出版年
2024年 | 4篇 |
2023年 | 49篇 |
2022年 | 102篇 |
2021年 | 109篇 |
2020年 | 102篇 |
2019年 | 152篇 |
2018年 | 126篇 |
2017年 | 138篇 |
2016年 | 134篇 |
2015年 | 132篇 |
2014年 | 308篇 |
2013年 | 293篇 |
2012年 | 263篇 |
2011年 | 389篇 |
2010年 | 307篇 |
2009年 | 352篇 |
2008年 | 312篇 |
2007年 | 351篇 |
2006年 | 334篇 |
2005年 | 310篇 |
2004年 | 213篇 |
2003年 | 197篇 |
2002年 | 177篇 |
2001年 | 123篇 |
2000年 | 124篇 |
1999年 | 100篇 |
1998年 | 76篇 |
1997年 | 79篇 |
1996年 | 50篇 |
1995年 | 66篇 |
1994年 | 82篇 |
1993年 | 44篇 |
1992年 | 57篇 |
1991年 | 52篇 |
1990年 | 46篇 |
1989年 | 39篇 |
1988年 | 43篇 |
1987年 | 20篇 |
1986年 | 14篇 |
1985年 | 13篇 |
1984年 | 4篇 |
1983年 | 4篇 |
1982年 | 6篇 |
1981年 | 3篇 |
1980年 | 4篇 |
1979年 | 1篇 |
1978年 | 1篇 |
排序方式: 共有5905条查询结果,搜索用时 15 毫秒
11.
合肥地区献血员感染HBV和HCV危险因素的多因素分析 总被引:2,自引:0,他引:2
用ELISA法检测了合肥地区1440名献血员抗HCV和乙肝五项指标,抗HCV阳性率为55%;HBsAg携带率为15%,HBV总感染率437%。分别以抗HCV阳性与感染过HBV的献血员为病例,以抗HCV阴性与未感染HBV的献血员为对照进行了HCV和HBV感染危险因素的单因素和多因素分析。结果显示,ALT、献血次数、献血量、文化程度、献血员心理和输血史与HCV感染有关;血型、家庭人口数和家庭子女数与HBV感染有关。 相似文献
12.
Effectsofhammerheadribozyme(RCP)onHBVPgeneinvitroGanLixia(甘立霞),WangPing(王平),ZhuXihua(朱锡华),DongYanlin(董燕麟),HouYunde(侯云德)(Depar... 相似文献
13.
14.
Manabu Daikoku Keisuke Nakata Keisuke Hamasaki Akio Ido Kazuhiko Nakao Yuji Kato Michiaki Koga Michitami Yano Shigenobu Nagataki 《Journal of medical virology》1995,47(2):184-188
Hepatitis B virus (HBV), with a G-to-A point mutation at nucleotide 83 in the precore region (mutant HBV83), accounts for most cases of hepatitis B e antigen (HBeAg)-defective HBV. However, it is still not clear how mutant HBV83 is associated with HBe seroconversion. Twenty-six HBeAgpositive patients with chronic hepatitis B who received oral prednisolone (30 mg/day) for 3 weeks were studied to clarify the prevalence of mutant HBV83 during the treatment using polymerase chain reaction with a restriction fragment length polymorphism assay. Twelve (46%) patients seroconverted to anti-HBe 1 year after treatment, whereas 14 (54%) did not. The proportion of mutant HBV83 to whole HBV remained unchanged in both groups during an acute exacerbation induced by withdrawal of corticosteroids. Among 12 anti-HBe-0seroconverted patients, five (56%) of nine patients with only wild-type HBV at baseline developed detectable levels of mutant HBV83 while all three patients with a mixed viral population of wild-type HBV and mu tant HBV83 at baseline developed a higher pro portion of mutant HBV83 one year after treat ment. In contrast, these changes were observed in only one (14%) of seven who failed to seroconvert. The results indicate that a flare-up of hepa titis precedes emergence or selection of mutant HBV83, followed by HBe seroconversion in patients with chronic hepatitis B. © 1995 WiIey-Liss, Inc. 相似文献
15.
Hepatitis B virus (HBV) is a virus that infects about 350,000,000 people worldwide with a clinical spectrum of acute hepatitis, the healthy carrier state, cirrhosis and hepatocellular carcinoma (HCC). The outcome of HBV infection is the result of complicated viral-host interactions. As in other infections with non-cythopatic viruses, the immune response is thought to play a crucial role in disease pathogenesis but there is increasing evidence that a variety of viral mechanisms, some depending on the function of virally encoded proteins, have a profound impact on the infected hepatocytes, the liver microenvironment, and host anti-viral responses. Indeed, the virus has evolved multiple mechanisms to ensure its success in infecting a susceptible host. The essential aspects of the life cycle of HBV and the host immune response are reviewed and recent new developments in the molecular virology of HBV, including experimental animal models, in the role of accessory viral proteins in disease pathogenesis and HCC development and in the characterisation of the T cell response in the control of HBV infection, are highlighted. 相似文献
16.
Teles SA Martins RM Gomes SA Gaspar AM Araujo NM Souza KP Carneiro MA Yoshida CF 《Journal of medical virology》2002,68(1):41-49
A serological and molecular study of hepatitis B virus (HBV) infection was carried out in dialysis units in Central Brazil. Between 1995 and 1999, serum samples from all HBsAg-positive hemodialysis patients (n = 43) were tested for HBeAg/anti-HBe and subtyping by monoclonal ELISA. HBV DNA was detected by PCR and positive samples were genotyped by restriction fragment polymorphism pattern (RFLP) methodology. TheHBsAg prevalence declined in this population during the survey period (12-5.8%). HBeAg and anti-HBe were detected in 23 (53.5%) and 18 (41.9%) sera, respectively. Thirty-six samples could be HBsAg subtyped: 21 were subtype ayw(3), 14 belonged to adw(2) and one was identified as adw(4). HBV DNA was present in 30 serum samples. Of these, 20 (66.7%) were genotype D, 9 (30%) genotype A, and 1 (3.3%) genotype F. In addition, the RFLP pattern could be determined in samples from 18/20 genotype D patients: D3 (10 strains), D7 (7 strains) and D4 (1 strain); from 8/9 genotype A patients: A1 (6 strains) and A3 (2 strains); and from the patient infected with genotype F: F1. Patterns D3 and D7 were associated closely with HBV infection in the two largest hemodialysis units studied. These findings confirm the value of the RFLP method as an effective molecular epidemiological tool for elucidating HBV transmission in hemodialysis units. 相似文献
17.
Molecular and serological evaluation of surface antigen negative hepatitis B virus infection in blood donors from Venezuela 总被引:2,自引:0,他引:2
Gutiérrez C Devesa M Loureiro CL León G Liprandi F Pujol FH 《Journal of medical virology》2004,73(2):200-207
Surface antigen negative hepatitis B virus (HBV) infection was evaluated in Venezuela, by molecular characterization of blood samples positive for antibodies to core antigen (anti-HBc) and negative for surface antigen (HBsAg) in blood donors (residual infections). HBV DNA was found in 11/258 samples (4.3%), and was significantly associated with high levels of anti-HBc antibodies (>25 UI/ml, P < 0.05), while no correlation was found between the presence of HBV DNA and the levels of anti-HBs. Synonymous and non-synonymous mutations were found in the HBV surface region (but not vaccine escape mutants) and in the precore/core region (precore mutants in 2/7 samples and 33-45 bp deletions near the N-terminal core region in 4/19 samples). While HBV genotype F prevails among HBsAg positive samples from blood donors in Venezuela, residual infection isolates were mainly genotypes A and D. Phylogenetic analysis of viral surface and core region revealed discrepancies in genotype designation in 6/9 samples, suggesting the presence of mixed infection or recombination. In conclusion, HBV residual infection in Venezuela does not seem to be frequently observed in HBV genotype F. This type of infection is frequently associated with variants exhibiting mutations in the surface gene that might be affecting the correct recognition by commercial tests, with precore mutants and with core internal deletions. These variants do not seem to cause severe liver disease, and on the contrary, were found circulating at low viremia. 相似文献
18.
Hironobu Tawaraya Showgo Ohkoshi Kenji Kuwana Masashi Watanabe Tomoteru Kamimura And Hitoshi Asakura 《Journal of medical virology》1995,45(4):367-372
Mass screening for hepatitis C virus antibody was carried out in 875 inhabitants (313 men and 562 women) of a town in Japan with a high rate of hepatitis B virus infection. The overall rate of positivity for anti-HCV was 8.8% (6.4% in men and 10,1% in women). The rate of positivity for hepatitis B virus surface antigen was 11.2%. Five subjects (0.6%) were positive for both markers. HCV-RNA was detected in 65 (88.4%) of 77 individuals who were positive for anti-HCV and in 1 (1.5%) of 60 individuals negative for anti-HCV. The genotype of the HCV genome was determined by PCR analysis using type-specific primers in 60 individuals. HCV type 1b was detected in 51 subjects (85%), type 2a in 3 subjects (5%), and type 2b in 6 subjects (10%). None of the individuals was infected with more than one genotype. The nucleotide sequences of the partial nonstructural 5 region of HCV type 1b genotype obtained from 6 individuals showed at least 92.0% homology in the nucleotide sequence, and 94.8% homology in the amino acid sequence. Homology among these clones was greater than their homology with previously described type 1 b sequences. The findings suggest that there was a specific local origin of HCV infection, although it was not possible to identify any single source of HCV infection. The results also indicate the presence of asymptomatic HCV carriers. © 1995 Wiley-Liss, Inc. 相似文献
19.
NF-κB在人肝细胞肝癌中的表达及与HBV X蛋白的关系 总被引:2,自引:0,他引:2
目的:研究核转录因子NF--κB在人肝细胞肝癌组织中的表达及其与乙型肝炎病毒(HBV )X蛋白的关系。方法;用免疫组织化学S-P法,检测52例人肝细胞肝癌组织中核转录因子NF--κB及HBV X蛋白的表达;用脂质体介导的基因转染法将HBV x基因真核表达载体pcDNA3.1-HBX转染入人肝癌细胞系HCC-9204,检测肝癌细胞内核转录因子NF--κB的表达。结果:52例人肝细胞肝癌组织均有核转录因子NF--κB的广泛表达,并且在11例HBV X蛋白阳性的肝癌组织,核转录因子NF--κB位于细胞胞质和胞核,而在41例HBV X蛋白阴性的肝癌组织,核转录因子NF--κB位于肝癌细胞的胞质。将HBV x基因真核表达载体pcDNA3.1-HBX转染 入人肝癌细胞系HCC-9204,并在稳定表达X蛋白 的肝癌细胞,核转录因子NF--κB定位于其胞质和胞核,而未进行基因转染的亲体细胞,核转录因子NF--κB仅定位于细胞质,细胞核无核转录因子NF--κB的表达。结论:核转录因子NF--κB在人肝细胞肝癌组织中广泛表达,人肝细胞肝癌中存在着核转录因子NF--κB的异常激活,并且核转录因子NF--κB的异常激活与HBV X蛋白有关,X蛋白激活核转录因子NF--κB, 使其从细胞转位于细胞核,这可能在HBV相关的人原发性肝癌肝癌的发生中起一定作用。 相似文献
20.
Carlo Delfini Anna Rosa Garbuglia Elena Alfani Antonino Di Caro Pietro Sette Arrigo Benedetto 《Journal of medical virology》1993,41(2):114-119
Several reports show that the prevalence of HBV (hepatitis B virus) carriers in HIV (human immunodeficiency virus) infected populations is significantly higher than in HIV seronegative individuals, independent of the risk group for HIV, that is, homosexuals or drug abusers. In this context, evaluation of the simultaneous presence of HBV and HIV in PBMCs (peripheral blood monuclear cells) is of particular interest for at least 2 reasons: 1) the possible reciprocal influence of the 2 viruses when they infect the same cell; 2) the possibility that HIV-iduced hematological disorders could indirectly influence the settling of HBV in blood cell populations. We report data on the frequency of PCR positivity for HBV DNA in PBMCs from 62 HIV infected patients, rigorously selected by risk group, that is, intravenous use of heroin for at least 3 years and syringe promiscuity. Sixtyseven HIV negative individuals who never used any drug formed the control group. The analysis of the cases positive for HBV DNA in PBMCs showed that 1) the overall prevalence of PCR positivity found in HIV infected patients was significantly lower than that registered in the control group; 2) PCR positivity among the subjects who were HBsAg negative and anti-HBV positive was extremely low in the HIV infected patients (3.7%) but quite frequent in the HIV negative subjects (37.0%). The results support the hypothesis that, unlike the HIV negative individuals, our HIV infected patients exhibited HBV DNA in PBMCS almost exclusively when they presented with active HBV replication. 相似文献